作为内皮功能障碍的标志物,蛋白尿一直被认为是终末期肾病进展的危险因子。近年来的研究发现蛋白尿也是心血管病发病和死亡的独立危险因素。除了ACEI以及ARB药物外,几乎没有能够影响蛋白尿进程的治疗方法。但是人们注意到他汀类药物降低心血管发病及病死率不仅仅是影响了LDL胆 As a marker of endothelial dysfunction, proteinuria has long been considered as a risk factor for the progression of end-stage renal disease. Recent studies have found that proteinuria is also an independent risk factor for cardiovascular disease and death. In addition to ACEI and ARB drugs, there is almost no treatment that affects the course of proteinuria. But people noticed that statins reduce cardiovascular morbidity and mortality not only affect the LDL gallbladder